Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carlen, P. L.
Right arrow Articles by Wilkinson, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carlen, P. L.
Right arrow Articles by Wilkinson, D. A.
NEUROLOGY 1980;30:956
© 1980 American Academy of Neurology

Prolonged cerebrospinal fluid acidosis in recently abstinent chronic alcoholics

P. L. Carlen, B. Kapur, L. A. Huszar, M. A. Lee, G. Moddel, R. Singh and D. A. Wilkinson

From the Addiction Research Foundation Clinical Institute (Drs. Carlen, Kapur, Huszar, Lee, Moddel, Singh, and Wilkinson), and the Toronto Western Hospital, Department of Medicine (Neurology), Playfair Neuroscience Unit (Drs. Carlen and Lee), University of Toronto, Toronto, Ontario.

Significant cerebrospinal fluid (CSF) acidosis was evident in 80 chronic alcoholics (mean pH, 7.25 ± 0.06) who were compared with 14 neurologic controls (mean pH, 7.31 ± 0.02). Acidosis persisted for many weeks after the last drink, and there was no associated systemic acidosis. CSF pH correlated significantly with CSF anion gap, suggesting a primary cerebral metabolic abnormality. Even though one-quarter of the alcoholic patients had a CSF pH less than 7.21, mental impairment was less than expected for the degree of CSF acidosis noted.

Address correspondence and reprint requests to Dr. Carlen, 33 Russell Street, Toronto, Ontario, Canada M5S 2S1.

Accepted for publication November 30, 1979.

Presented in part at the thirty-first annual meeting of the American Academy of Neurology, Chicago, April 1979.

This work was supported in part by the Non-Medical Use of Drugs Directorate of Canada.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by AAN Enterprises, Inc.